Schilddrüsenfunktionsstörungen im Alter

Schilddrüsenfunktionsstörungen gehören zu den häufigsten endokrinologischen Krankheitsbildern. Mit zunehmender Lebenserwartung steigt auch die Zahl der betroffenen älteren Patienten. Gleichzeitig sind Veränderungen der Schilddrüsenhormonphysiologie Teil des Alterungsprozesses, sodass Diagnostik und Therapie in Abhängigkeit vom Lebensalter variieren. Der Beitrag beleuchtet die Besonderheiten bei älteren Patienten mit Schilddrüsenfehlfunktionen.

Schlüsselwörter

Hypothyreose - Hyperthyreose - Therapie im Alter

• Literatur

• 1 Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC. et al. Hypothalamus-Pituitary-Thyroid Axis. Compr Physiology 2016; 6: 1387-1428
• 2 Weitzel JM, Iwen KA. Coordination of mitochondrial biogenesis by thyroid hormone. Mol Cell Endocrinol 2011; 342: 1-7
• 3 Iwen KA, Oelkrug R, Brabant G. Effects of thyroid hormones on thermogenesis and energy partitioning. J Mol Endocrinol 2018; 60: R157-r1703
• 4 Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA 2019; 322: 153-160
• 5 Iwen KA, Brabant G. Therapie mit Schilddrüsenhormonen im Alter. Internist 2020; 61: 541-548
• 6 Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011; 21: 5-11
• 7 Burch HB. Drug Effects on the Thyroid. N Engl J Med 2019; 381: 749-761
• 8 Biondi B, Cooper DS. Subclinical Hyperthyroidism. N Engl J Med 2018; 378: 2411-2419
• 9 Jasim S, Gharib H. Thyroid and aging. Endocr Pract 2018; 24: 369-374
• 10 Biondi B, Bartalena L, Cooper DS. et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyr J 2015; 4: 149-163
• 11 Iwen KA. Schilddrüsensonografie – Schritt für Schritt. Dtsch Med Wochenschr 2020; 145: 260-267
• 12 Selmer C, Olesen JB, Hansen ML. et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metabol 2014; 99: 2372-2382
• 13 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26: 1343-1421
• 14 Wiersinga WM, Duntas L, Fadeyev V. et al. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyr J 2012; 1: 55-71
• 15 Taylor PN, Iqbal A, Minassian C. et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Internal Med 2014; 174: 32-39
• 16 Zulewski H, Muller B, Exer P. et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metabol 1997; 82: 771-776
• 17 Stott DJ, Rodondi N, Bauer DC. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med 2017; 377: e20
• 18 de Montmollin M, Feller M, Beglinger S. et al. L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial. Ann Internal Med 2020; 172: 709-716
• 19 Lillevang-Johansen M, Abrahamsen B, Jorgensen HL. et al. Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol 2019; 180: 407-416